MEDICLIN Aktiengesellschaft

FSX:MED.DE

2.38 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 730.071704.7673.1659.9673.1645.1609.1580.344555.348538.035514.954509.739493.563487.167470.579456.79500370.434373.026376.139
Cost of Revenue 682.09132.8122.1112.7121119.4112.61108.675103.067106.94110.951111.155110.436110.329107.419105.586-84.405-80.31176.14273.20175.453
Gross Profit 47.981571.9551547.2552.1525.7496.49471.669452.281431.095404.003398.584383.127376.838363.161351.20984.40580.311294.292299.825300.686
Gross Profit Ratio 0.0660.8120.8190.8290.820.8150.8150.8130.8140.8010.7850.7820.7760.7740.7720.769000.7940.8040.799
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 14.79.38.79.610.28.69.58.58.37.16.47.6000000174.748172.621175.26
Selling & Marketing Expenses 3.33.20000000000000000000
SG&A 70.0349.38.79.610.28.69.58.58.37.16.47.6000000174.748172.621175.26
Other Expenses 1.1544.128531.404538.295520.4750.90.90.90.90.80.80.70000-65.54-63.588000
Operating Expenses 70.034553.428540.104547.895530.675511.574490.756448.519429.605416.318402.6394.994372.261359.97346.199335.409-65.54-63.58827.37119.28419.718
Operating Income -22.05419.5211.5630.30522.41215.0636.61624.02423.60915.5632.1484.27710.86616.86916.96215.79918.86516.72316.096280.541280.968
Operating Income Ratio -0.030.0280.01700.0330.0230.0110.0410.0430.0290.0040.0080.0220.0350.0360.035000.0430.7520.747
Total Other Income Expenses Net 13.365-9.743-9.117-10.393-10.802-2.263-2.36-3.123-3.602-3.877-4.718-5.059-5.122-5.295-5.344-6.66300-6.466-294.303-297.278
Income Before Tax -8.6899.7772.446-10.08811.61111.8624.25620.920.00811.686-2.57-0.7825.74411.57411.6189.136009.63-13.762-16.31
Income Before Tax Ratio -0.0120.0140.004-0.0150.0170.0180.0070.0360.0360.022-0.005-0.0020.0120.0240.0250.02000.026-0.037-0.043
Income Tax Expense 2.0350.0580.961-1.0541.9284.0980.2954.2993.413.3230.1710.6952.7671.4741.261.863001.854-293.684-295.461
Net Income -10.7769.4411.461-9.0359.6627.7173.90816.54616.5368.503-2.638-1.4032.97710.110.3597.273007.776-13.644-16.956
Net Income Ratio -0.0150.0130.002-0.0140.0140.0120.0060.0290.030.016-0.005-0.0030.0060.0210.0220.016000.021-0.037-0.045
EPS -0.230.20.031-0.190.20.160.080.350.350.18-0.056-0.030.060.210.220.22000.26-0.46-0.54
EPS Diluted -0.230.20.031-0.190.20.160.080.350.350.18-0.056-0.030.060.210.220.22000.25-0.46-0.54
EBITDA 63.95291.80485.4377.65393.74837.6227.20843.30642.11734.11719.7121.7727.96330.9131.64327.8693.12188.842273.9989.916.328
EBITDA Ratio 0.0880.130.1270.1180.1390.0580.0450.0750.0760.0630.0380.0430.0570.0630.0670.061000.740.0270.017